Novel mutations consolidate <i>KCTD7</i> as a progressive myoclonus epilepsy gene

Abstract

These data confirm the causality of KCTD7 defects in PME, and imply that KCTD7 mutation screening should be considered in PME patients with onset around 2 years of age followed by rapid mental and motor deterioration.